awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q51731100-9C8DC2FD-9107-4AE8-8AA1-BF4AC42C24FA
Q51731100-9C8DC2FD-9107-4AE8-8AA1-BF4AC42C24FA
BestRank
Statement
http://www.wikidata.org/entity/statement/Q51731100-9C8DC2FD-9107-4AE8-8AA1-BF4AC42C24FA
The SGLT2 Inhibitor Dapagliflozin Significantly Improves the Peripheral Microvascular Endothelial Function in Patients with Uncontrolled Type 2 Diabetes Mellitus.
P2860
Q51731100-9C8DC2FD-9107-4AE8-8AA1-BF4AC42C24FA
BestRank
Statement
http://www.wikidata.org/entity/statement/Q51731100-9C8DC2FD-9107-4AE8-8AA1-BF4AC42C24FA
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
7bfceb2d8df9289aeaea9515e57f20d58891d4cc
P2860
Dapagliflozin as monotherapy or combination therapy in Japanese patients with type 2 diabetes: an open-label study.